Titlebook: Central Nervous System Diseases; Innovative Animal Mo Dwaine F. Emerich (Director of Neuroscience),Regin Book 2000 Springer Science+Busines

關(guān)稅

書(shū)目名稱Central Nervous System Diseases影響因子(影響力)




書(shū)目名稱Central Nervous System Diseases影響因子(影響力)學(xué)科排名




書(shū)目名稱Central Nervous System Diseases網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Central Nervous System Diseases網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Central Nervous System Diseases被引頻次




書(shū)目名稱Central Nervous System Diseases被引頻次學(xué)科排名




書(shū)目名稱Central Nervous System Diseases年度引用




書(shū)目名稱Central Nervous System Diseases年度引用學(xué)科排名




書(shū)目名稱Central Nervous System Diseases讀者反饋




書(shū)目名稱Central Nervous System Diseases讀者反饋學(xué)科排名

Chronological

iseases. Coverage includes novel uses of animal models of Alzheimer‘s, Parkinson‘s, and Huntington‘s diseases, and studies of aging. Techniques that rely heavily on behavioral analyses, as well as models developed from infusions of neurotoxins and from advances in molecular biology, are thoroughly e

CHOKE

Ingest

MEEK

Antisense Knockdown of Dopamine Receptors mediate a myriad of functions in the CNS ranging from movement to emotion as well as being involved in a number of pathologies, including Parkinson’s disease (PD), schizophrenia, Huntington’s disease, and tardive dyskinesia ..

faction

faction

M. L. Getchell,B. Zielinski,T. V. Getchellllion annually .. The emotional and social impact of the disease is immeasurable. With advances in general healthcare contributing to greater longevity, 8 million Americans are expected to develop AD by the first quarter of the 21st century unless parallel advances are made in the treatment of AD to alter the devastating course of this disease.

閃光東本

https://doi.org/10.1007/978-3-642-71874-8 of the disorder may come from early detection and interventions that have quite general neuroprotective properties. Behavior-based diagnostic assessment aimed at detecting threshold level neuropathology would be critical, both in clinical practice and preclinically.

enterprise

Book 2000 Nervous System Diseases: Innovative Animal Models from Lab to Clinic offers neuroscientists, pharmacologists, and interested clinicians a unique survey of the most productive animal models of the leading neurological diseases currently employed to develop today‘s innovative drug therapies.

foliage